LGND
Ligand Pharmaceuticals Incorporated
293.30$
-1.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 187.1 | – | – | 203.1 | 121.7 | 143.6 | 48.4 | 26.4 | 23.0 | 12.4 | 2.2 | 2.1 | 2.0 | 1.8 | – | – | – | – | 41.8 | 29.3 | 21.8 | 28.2 | 49.9 | – | – | – | 55.2 | 47.1 | 63.2 | 24.2 | 13.7 | 36.1 | 40.8 | – | – | – | 73.5 | 32.1 | 25.9 | 35.0 | |
| 15.9 | 12.2 | 14.0 | 15.0 | 15.5 | 12.8 | 15.2 | 13.7 | 17.0 | 7.1 | 7.0 | 8.0 | 7.6 | 9.3 | 6.8 | 9.2 | 6.7 | 5.6 | 7.9 | 5.6 | 5.4 | 5.8 | 4.6 | 4.2 | 4.2 | 6.5 | 7.3 | 8.2 | 8.0 | 9.6 | 11.2 | 11.4 | 12.1 | 12.2 | 11.1 | 12.1 | 14.2 | 14.9 | 14.5 | 23.8 | |
| 4.0 | 3.6 | 3.8 | 4.3 | 4.7 | 4.3 | 5.1 | 5.1 | 5.9 | 3.2 | 1.5 | 1.3 | 1.4 | 1.5 | 1.1 | 1.7 | 1.4 | 1.5 | 2.2 | 1.8 | 1.8 | 2.0 | 1.5 | 1.2 | 1,127.3 | 1.9 | 2.0 | 1.9 | 1.6 | 1.8 | 1.6 | 2.0 | 2.2 | 2.4 | 2.5 | 2.7 | 3.8 | 3.9 | 4.0 | 7.1 | |
| 16.9 | 12.8 | 15.9 | 15.4 | 17.0 | 13.0 | 16.3 | 13.1 | 19.9 | 6.8 | 3.7 | 4.1 | 4.6 | 14.1 | 4.2 | 6.4 | 6.7 | 7.7 | 9.4 | 6.8 | 6.5 | 6.9 | 5.2 | 4.7 | 4.2 | 6.7 | 7.3 | 8.0 | 7.8 | 9.4 | 10.8 | 11.3 | 11.7 | 11.7 | 10.9 | 11.7 | 15.4 | 15.9 | 15.7 | 24.2 | |
| 36.7 | 26.5 | 34.0 | 30.3 | 31.9 | 23.2 | 21.5 | 13.5 | 15.9 | 7.2 | 4.5 | 8.8 | – | 44.2 | 167.2 | 18.6 | 21.2 | 32.1 | 23.1 | 24.2 | 18.7 | 22.9 | 21.0 | 16.8 | 14.4 | 9.6 | 7.2 | 7.3 | 7.2 | 12.3 | 8.1 | 16.8 | 18.4 | 48.1 | – | – | 38.8 | 21.8 | 19.4 | 25.7 | |
| 53.7 | 38.2 | 32.8 | 27.1 | 26.2 | 20.9 | 20.1 | 16.6 | 21.7 | 9.8 | 10.0 | 42.3 | – | – | – | 47.7 | 23.1 | 21.9 | 43.5 | 47.3 | 40.0 | 24.2 | 11.1 | 9.8 | 9.9 | 9.5 | 12.8 | 13.1 | 11.6 | 28.0 | 41.2 | 34.8 | 31.4 | 25.5 | 56.8 | 56.8 | 116.4 | 82.0 | 32.3 | 52.5 | |
| 1.9% | 2.6% | 3.1% | 3.7% | 3.8% | 4.8% | 5.0% | 6.0% | 4.6% | 10.2% | 10.0% | 2.4% | 0.0% | -2.8% | -8.0% | 2.1% | 4.3% | 4.6% | 2.3% | 2.1% | 2.5% | 4.1% | 9.0% | 10.2% | 10.1% | 10.5% | 7.8% | 7.6% | 8.6% | 3.6% | 2.4% | 2.9% | 3.2% | 3.9% | 1.8% | 1.8% | 0.9% | 1.2% | 3.1% | 1.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 96.1% | 94.9% | 95.4% | 95.6% | 94.9% | 96.2% | 96.5% | 97.4% | 97.9% | 97.5% | 96.1% | 93.9% | 91.9% | 90.6% | 88.9% | 86.2% | 85.6% | 83.7% | 83.7% | 77.4% | 77.5% | 77.6% | 77.3% | 81.9% | 80.2% | 69.4% | 71.3% | 73.7% | 76.6% | 92.0% | 84.9% | 99.3% | 93.5% | 93.4% | 97.3% | 87.7% | 85.9% | 97.5% | 98.6% | 98.6% | |
| 39.1% | 40.6% | 36.3% | 41.0% | 45.9% | 48.2% | 56.5% | 66.1% | 65.6% | 65.1% | 399.2% | 505.9% | 556.3% | 671.0% | -14.3% | -3.5% | 3.1% | 13.9% | 12.8% | 26.0% | 28.2% | 28.5% | 29.5% | 17.5% | 16.4% | 20.4% | 26.3% | 23.5% | 21.1% | 9.1% | 0.6% | -12.3% | -10.7% | -13.5% | -34.1% | -18.3% | 7.0% | 17.6% | 36.7% | 34.7% | |
| 8.5% | -1.5% | -2.9% | 7.4% | 12.8% | 8.9% | 31.4% | 52.1% | 73.8% | 57.0% | 320.1% | 389.6% | 388.7% | 523.2% | -55.6% | -19.5% | -11.2% | -1.6% | 18.8% | 19.0% | 24.9% | 20.6% | 9.1% | -3.6% | -9.8% | -19.3% | 13.3% | 17.3% | 12.7% | 39.7% | 81.4% | 31.6% | 29.7% | -2.4% | -73.1% | -40.4% | 19.3% | 46.4% | 55.9% | 67.9% | |
| 29.7% | 31.8% | 42.7% | 55.5% | 59.2% | 61.2% | 75.6% | 82.8% | 78.3% | 72.4% | 70.2% | 19.0% | -0.2% | -26.5% | -54.8% | 19.3% | 28.8% | 25.4% | 18.1% | 11.8% | 13.6% | 24.0% | 41.2% | 42.9% | 42.6% | 68.8% | 57.3% | 62.4% | 68.9% | 34.4% | 27.2% | 32.7% | 38.5% | 47.8% | 19.6% | 21.3% | 12.2% | 18.2% | 44.8% | 45.2% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| 2.1% | -0.4% | -0.8% | 2.1% | 3.9% | 3.0% | 10.6% | 19.3% | 25.6% | 25.6% | 70.8% | 65.0% | 69.9% | 82.0% | -9.2% | -3.5% | -2.3% | -0.4% | 5.3% | 6.1% | 8.4% | 7.0% | 3.0% | -1.0% | -2,608.4% | -5.6% | 3.7% | 4.1% | 2.5% | 7.4% | 11.9% | 5.4% | 5.4% | -0.5% | -16.7% | -9.2% | 5.1% | 12.2% | 15.4% | 20.4% | |
| 1.3% | -0.3% | -0.5% | 1.4% | 2.5% | 1.9% | 7.0% | 6.4% | 8.5% | 11.4% | 39.9% | 37.6% | 38.4% | 42.1% | -5.2% | -2.0% | -1.3% | -0.2% | 3.0% | 3.8% | 5.4% | 4.4% | 2.1% | -0.7% | -2,026.6% | -4.4% | 3.0% | 3.6% | 2.1% | 6.6% | 10.5% | 4.9% | 4.7% | -0.4% | -14.6% | -8.0% | 3.3% | 8.0% | 10.0% | 9.0% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 86 | 72 | 205 | 46 | 189 | 26 | 177 | -151 | 700 | -82 | -784 | -680 | -467 | 569 | -293 | -358 | -0.9 | 403 | 328 | 296 | 296 | 303 | 163 | 112 | 2.3 | 32 | -11 | -28 | -19 | -23 | -49 | -17 | -63 | -71 | -47 | -67 | 307 | 272 | 333 | 121 | |
| 2.0 | 1.4 | 4.0 | 0.8 | 2.7 | 0.3 | 1.4 | -0.7 | 2.3 | -0.3 | -4.0 | -8.4 | – | 14.9 | -107.2 | -8.3 | 0.0 | 9.0 | 3.9 | 4.2 | 3.1 | 3.6 | 2.5 | 1.8 | 0.0 | 0.3 | -0.1 | -0.2 | -0.1 | -0.2 | -0.3 | -0.2 | -0.6 | -1.7 | – | – | 3.1 | 1.4 | 1.5 | 0.4 | |
| 61.6% | 61.6% | 63.3% | 64.0% | 64.1% | 62.4% | 65.9% | 33.4% | 33.2% | 44.5% | 56.4% | 57.8% | 55.0% | 51.3% | 55.8% | 55.9% | 55.9% | 52.1% | 57.6% | 62.6% | 63.8% | 63.3% | 71.8% | 74.5% | 77.7% | 78.3% | 79.7% | 87.7% | 86.8% | 89.0% | 88.3% | 89.5% | 88.1% | 88.2% | 87.9% | 87.3% | 64.3% | 65.2% | 65.1% | 44.3% | |
| 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1.3 | 1.2 | 1.1 | 0.6 | 0.6 | 0.7 | 0.8 | 0.7 | 0.6 | 0.7 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 2.9 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.4 | 0.4 | 1.2 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| 0.34 | -0.08 | -0.14 | 0.37 | 0.70 | 0.59 | 2.13 | 4.90 | 7.43 | 6.80 | 35.93 | 34.60 | 31.66 | 36.50 | -3.70 | -1.48 | -1.00 | -0.18 | 2.28 | 2.79 | 3.99 | 3.41 | 1.41 | -0.47 | -1.24 | -1.98 | 1.33 | 1.53 | 0.95 | 2.95 | 5.32 | 2.34 | 2.46 | -0.21 | -6.91 | -3.81 | 2.41 | 5.89 | 7.72 | 9.03 | |
| 4.00 | 5.21 | 4.72 | 5.04 | 5.47 | 6.68 | 6.77 | 9.41 | 10.08 | 11.93 | 11.22 | 8.88 | 8.14 | 6.98 | 6.65 | 7.57 | 8.92 | 11.17 | 12.08 | 14.66 | 16.02 | 16.56 | 15.36 | 13.28 | 12.74 | 10.24 | 10.04 | 8.83 | 7.49 | 7.43 | 6.53 | 7.40 | 8.28 | 8.81 | 9.46 | 9.41 | 12.46 | 12.68 | 13.80 | 13.31 | |
| 16.11 | 17.75 | 17.32 | 17.63 | 18.04 | 19.83 | 20.05 | 25.36 | 29.08 | 26.62 | 50.76 | 53.25 | 45.32 | 44.50 | 40.04 | 41.63 | 43.39 | 42.53 | 43.24 | 45.80 | 47.37 | 49.07 | 47.15 | 47.57 | 0.05 | 35.38 | 35.96 | 37.50 | 38.43 | 39.65 | 44.51 | 43.00 | 45.67 | 43.77 | 41.45 | 41.58 | 47.11 | 48.12 | 50.16 | 44.31 | |
| 1.19 | 1.66 | 2.02 | 2.80 | 3.24 | 4.09 | 5.12 | 7.79 | 7.89 | 8.65 | 7.88 | 1.69 | -0.02 | -1.85 | -3.64 | 1.46 | 2.57 | 2.84 | 2.19 | 1.73 | 2.17 | 3.98 | 6.33 | 5.70 | 5.43 | 7.04 | 5.75 | 5.52 | 5.16 | 2.55 | 1.77 | 2.42 | 3.19 | 4.21 | 1.85 | 2.00 | 1.52 | 2.31 | 6.18 | 6.02 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.